Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02099851

Ligand	Ligand name	Chain	PDB	Tanimoto
MY3	[N-(3-BENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO] - ACETIC ACID	A,I	2CNL	0.75
744	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	A	2H7N	0.75
V35	D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID	B,C	2VGC	0.77
22U	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	H,I	2ZC9	0.77
16U	N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide	H,I	3DT0	0.8
MY5	{1-[(3S)-4-{[(1S)-2-(BENZYLAMINO)-1-METHYL-2-OXOETHYL]AMINO}-3-HYDROXY-4-OXOBUTANOYL]HYDRAZINO}ACETIC ACID	I	2CNN	0.71
LAZ	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	A,B	1OJC	0.84
GB7	(3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)-1-methylpyrrolidin-2-one	A	3DDG	0.74
K7I	L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide	A,B	2QXG	0.72
176	1-(2-AMINO-3,3-DIPHENYL-PROPIONYL)-PYRROLIDINE-3-CARBOXYLIC ACID 2,5-DICHLORO-BENZYLAMIDE	A,B	1TA2	0.72
KHA	1-(4-{[(2-HYDROXYETHYL)AMINO]CARBONYL}BENZYL)-1-METHYLPIPERIDINIUM	H,L,X,Y	1UWG	0.75
MN2	1-CARBOXYETHYLAMINOMETHYL-4-AMINOMETHYLBENZENE	N	1NLO	0.71
468	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	A	2H7P	0.74
MY4	(1-{(3S)-3-HYDROXY-4-OXO-4-[(2-PHENYLETHYL)AMINO]BUTANOYL}HYDRAZINO)ACETIC ACID	A	2CNO	0.71
GB3	(2R,3R,4S,5R)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)-5-METHYLPYRROLIDINE-3,4-DIOL	A	2F1B	0.71
23U	beta-phenyl-D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	H,I	3DHK	0.74
CRP	((1RS,3SR)-2,2-DICHLORO-N-[(R)-1-(4-CHLOROPHENYL)ETHYL]-1-ETHYL-3-METHYLCYCLOPROPANECARBOXAMIDE	A	2STD	0.75
CRP	((1RS,3SR)-2,2-DICHLORO-N-[(R)-1-(4-CHLOROPHENYL)ETHYL]-1-ETHYL-3-METHYLCYCLOPROPANECARBOXAMIDE	A,B,C	7STD	0.75
19U	1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide	H,I	2ZFP	0.8
CLD	D-PARA-CHLOROPHENYL-1-ACTEAMIDOBORONIC ACID ALANINE	A	1AVT	0.78
F55	N-{[(4-chlorophenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN3	0.7
CLB	D-PARA-CHLOROPHENYL-1-ACETAMIDOBORONIC ACID ALANINE	A	1VSB	0.78
53U	D-phenylalanyl-N-benzyl-L-prolinamide	H,I	2ZFF	0.71
GB6	(3R,4R,5R)-3,4-dihydroxy-5-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidin-2-one	A	3DDF	0.74
BAV	(3S,14R,16S)-16-[(1R)-1-hydroxy-2-{[3-(1-methylethyl)benzyl]amino}ethyl]-3,4,14-trimethyl-1,4-diazacyclohexadecane-2,5-dione	A,B,C	3DV5	0.73
MX3	(1-{4-[BENZYL(METHYL)AMINO]-4-OXOBUTANOYL}HYDRAZINO)ACETIC ACID	I	2C2O	0.71
F1H	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	A	2ZJH	0.7
V36	L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID	B,C	1VGC	0.77
GB1	(2R,3R,4S)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	A	2F18	0.71
J54	(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID	A	2V35	0.72
64U	3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide	H,I	3DUX	0.77
21U	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	H,I	2ZGB	0.8
GB2	(2R,3R,4S)-2-({[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	A	2F1A	0.71
MY1	[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID	I	2CDR	0.7
K7J	N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-prolinamide	A	2QXI	0.71
K7J	N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-prolinamide	A	2QXH	0.71
K7J	N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-prolinamide	A	2QXJ	0.71